COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,248 Articles (22,733 medRxiv, 8,515 bioRxiv)

Most recent first Previous |  Page 1684: Articles 16831-16840  | Next

SARS-CoV-2 Seroprevalence in 12 Cities of India from July-December 2020
Velumani, A., Nikam, C., Suraweera, W., Fu, S. H., Gelband, H., Brown, P. E., Bogoch, I., Nagelkerke, N., Jha, P.
10.1101/2021.03.19.21253429 — Posted: 2021-03-24
Characterising long COVID more than 6 months after acute infection in adults; prospective longitudinal cohort study, England
Amin-Chowdhury, Z., Harris, R. J., Aiano, F., Zavala, M., Bertran, M., Borrow, R., Linley, E., Ahmad, S., Parker, B., Horsley, A., Hallis, B., Flood, J., Brown, K. E., Amirthalingam, G., Ramsay, M. E., Andrews, N., Ladhani, S. N.
10.1101/2021.03.18.21253633 — Posted: 2021-03-24
SARS-CoV-2 genome sequencing from COVID-19 in Ecuadorian patients: a whole country analysis.
Marquez, S., Prado-Vivar, B., Guadalupe, J. J., Becerra-Wong, M., Gutierrez, B., Clinical COVID-19 Ecuador Consortium, , Fernandez-Cadena, J. C., Andrade-Molina, D., Morey, G., Barragan, V., Rojas-Silva, P., Trueba, G., Grunauer, M., Cardenas, P.
10.1101/2021.03.19.21253620 — Posted: 2021-03-24
Population homogeneity for the antibody response to COVID-19 Comirnaty vaccine is only reached after the second dose
Vania, J. F., Bergman, M.-L., Goncalves, L. A., Duarte, N., Borges, P. C., Diwo, C., Castro, R., Matoso, P., Malheiro, V., Brennand, A., Kosack, L., Akpogheneta, O., Figueira, J. M., Casaca, A. M., Cardoso, C., Alves, P. M., Penha-Goncalves, C., Demengeot, J.
10.1101/2021.03.19.21253680 — Posted: 2021-03-24
Seroprevalence of anti-SARS-CoV-2 IgG antibody among health care workers of anaesthesia departments from various hospital settings in India
Parai, D., Choudhary, H. R., Dash, G. C., Peter, A., Roy, R., Aggarwal, G., Sahoo, S., Rout, U. K., Nanda, R. R., Kshatri, J. S., Kanungo, S., Palo, S. K., Pati, S., Bhattacharya, D. D.
10.1101/2021.03.20.21253819 — Posted: 2021-03-24
Some Clinical and Immunological Features of Imported COVID-19 Cases in Mongolia
Sandag, T., Lkhagvasuren, E., Batmunkh, M., Ravjir, O.
10.1101/2021.03.17.21253849 — Posted: 2021-03-24
Comparison between one and two dose SARS-CoV-2 vaccine prioritisation for a fixed number of vaccine doses
Hill, E. M., Keeling, M. J.
10.1101/2021.03.15.21253542 — Posted: 2021-03-24
Accelerated RNA detection using tandem CRISPR nucleases
Liu, T. Y., Knott, G. J., Smock, D. C. J., Desmarais, J. J., Son, S., Bhuiya, A., Jakhanwal, S., Prywes, N., Agrawal, S., Diaz de Leon Derby, M., Switz, N. A., Armstrong, M., Harris, A. R., Charles, E. J., Thornton, B. W., Fozouni, P., Shu, J., Stephens, S. I., Kumar, G. R., Zhao, C., Mok, A., Iavarone, A. T., Escajeda, A. M., McIntosh, R., Kim, S. E., Dugan, E. J., IGI Testing Consortium, , Pollard, K. S., Tan, M. X., Ott, M., Fletcher, D. A., Lareau, L. F., Hsu, P. D., Savage, D. F., Doudna, J. A.
10.1101/2021.03.19.21253328 — Posted: 2021-03-24
Broad decline and subsequent differential re-emergence of respiratory viruses during COVID-19 pandemic response measures, Singapore 2020
Wan, W. Y., Thoon, K. C., Loo, L. H., Chan, K. S., Oon, L. L. E., Ramasamy, A., Maiwald, M.
10.1101/2021.03.23.21251968 — Posted: 2021-03-24 Discussion: Onsite
Mortality and Severity in COVID-19 Patients on ACEIs & ARBs - A Meta-Regression Analysis
Singh, R., Rathore, S. S., Khan, H., Bhurwal, A., Sheraton, M., Ghosh, P., Anand, S., Makadia, J., Ayesha, F., Mahapure, K., Mehra, I., Tekin, A., Kashyap, R., Bansal, V.
10.1101/2021.03.14.21253557 — Posted: 2021-03-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).